Belite Bio (BLTE) Common Equity (2020 - 2026)
Belite Bio (BLTE) reported Common Equity of $776.64 million for Q2 2026, up 418.2% from $149.89 million a year earlier but down 2.4% from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Belite Bio posted Common Equity of $770.49 million, up 428.4% from FY2024.
- Common Equity has increased for three consecutive years.
- By year, Common Equity came in at $145.82 million in FY2024 (+61.3%), $90.43 million in FY2023 (+117.9%), $41.5 million in FY2022 and -$15.09 million in FY2021.
- Five-year quarterly Common Equity spans a low of -$15.09 million in Q4 2021 and a high of $795.79 million in Q1 2026.
- Year over year, Common Equity has now increased in each of the last 11 quarters, with growth averaging 207.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Common Equity ranged from 12.3% (Q2 2023) to 428.4% (Q4 2025).
- Per Business Quant data, the three quarters before Q2 2026 came in at $795.79 million (Q1 2026), $770.49 million (Q4 2025) and $274.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Belite Bio | 6.53 Bn | 6.53 Bn | - | 776.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 776.64 Mn |
| Mar 31, 2026 | 795.79 Mn |
| Dec 31, 2025 | 770.49 Mn |
| Sep 30, 2025 | 274.08 Mn |
| Jun 30, 2025 | 149.89 Mn |
| Mar 31, 2025 | 158.07 Mn |
| Dec 31, 2024 | 145.82 Mn |
| Sep 30, 2024 | 112.20 Mn |
| Jun 30, 2024 | 114.59 Mn |
| Mar 31, 2024 | 96.47 Mn |
| Dec 31, 2023 | 90.43 Mn |
| Sep 30, 2023 | 52.79 Mn |
| Jun 30, 2023 | 55.72 Mn |
| Mar 31, 2023 | 35.17 Mn |
| Dec 31, 2022 | 41.50 Mn |
| Jun 30, 2022 | 49.63 Mn |
| Dec 31, 2021 | -15.09 Mn |
| Dec 31, 2020 | -7.04 Mn |
API Access
Belite Bio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();